Using its powerful artificial intelligence-driven Concentriq digital pathology platform, Proscia is accelerating breakthroughs in precision medicine. David West, Co-Founder and Chief Executive Officer of Proscia, explained that pathology has been a core component of research and diagnosis for more than 150 years. But, with advances in technology and machine learning capabilities, the field is shifting away from microscopes and glass slides and becoming a data-driven discipline that is more reliant on the use of high-resolution digital imagery.
Go with the Flow – Why Flow Cytometry has Become one of the Most Sought-After Biotech Job Skills, and How to be Competitive
In terms of lab techniques, flow cytometry is one of the most versatile out there when it comes to its biotech applications, and for good reason. Cell and gene therapies have gained considerable popularity in recent years, and the market is predicted to continue growing as we learn more information and become more savvy in how we engineer cells. And even if you’re not working directly in the cell therapy space, chances are you’ll still be utilizing flow to evaluate things such as how well a treatment worked or characterizing immune cell populations. From identifying biomarkers to cell sorting and everything in between, there’s little doubt that flow cytometry is an essential skill in today’s biotech ecosystem.
Cristina Rexach recently joined Workforce Genetics (WFGX) as a Senior Talent Consultant. Prior to joining WFGX, Cristina had a successful run as a Global MedTech Recruiter with the Mullings Group, a talent acquisition firm serving the medical device industry. She brings more than a decade of experience in the life sciences industry to her new role. Cristina had a highly successful career in healthcare management and sales before transitioning to the talent side of the industry.
Following the recent retirement of Jonathan Javitt in March, Robert Besthof, Head of Operations and Chief Commercial Officer, has taken over as interim chief executive officer of NRx Pharmaceuticals. He said there was a need for a CEO to be based in the U.S. alongside the rest of the team.
The quest for funding can be a stressful experience for entrepreneurs hoping to launch a biotech startup. The need for seed funding is essential but where are the best sources? And what are the proverbial strings attached to that kind of funding?
At Workforce Genetics we often find that clients and even some junior recruiters we speak with don’t quite understand the difference between Staffing Agencies and Search Firms when it comes to specifics within the recruiting industry.
After achieving several important clinical milestones, momentum and excitement has been building for months around the company’s lead pipeline candidate AGT103-T, which is a potential HIV functional cure. In the coming months, the company expects to have the latest data readout for its Phase I trial. AGT103-T is a single-dose HIV gene therapy that could potentially replace antiretroviral therapy (ART) with a functional cure.
Michael Doub has enjoyed a diverse professional path working in both the life sciences and manufacturing. Before coming to Eastern Analytical Labs, Michael co-founded Aireon Therapeutics Inc. where he served as CEO. Michael has a successful record of building operational systems and high performing teams that drive organizational growth from concept to commercialization. He has received a BA in Biology from Hood College, an MBA from University of Maryland and Operational Efficiency Certifications from Villanova University.
Tanner Ash recently joined BioNTech as Senior Specialist, Quality Assurance Operations. Tanner was most recently a Supervisor at Ellume, a global diagnostics company that develops, manufactures, and commercializes the next generation of digitally enabled diagnostic products for healthcare professionals and consumers.
In addition to his work with Ellume, over the past decade Tanner has held positions with Kite, VaLogic, and Lonza.
Located in the northern part of Maryland along the I-270 Technology Corridor, Frederick County is home to more than 80 bioscience companies. With proximity to Fort Detrick, home to the Frederick National Laboratory for Cancer Research, the county boasts a powerful environment of life sciences intellectual prowess.